Nebraska Methodist Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
Nebraska Methodist Cancer Center has participated in 17 clinical trials.
Therapeutic areas: Non Small Cell Lung Cancer, Metastatic Breast Cancer, Melanoma.
Sponsors: SCRI Development Innovations, LLC, Synta Pharmaceuticals Corp., Human Genome Sciences Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Methodist Cancer Center has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Methodist Cancer Center has 17 clinical trials on record. Their work covers Non Small Cell Lung Cancer, Metastatic Breast Cancer, Melanoma.
Nebraska Methodist Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.